reference/3602530

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3602530

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, P.H.S.
endingPage	2765
issn	0021-9738
issueIdentifier	11
pageRange	2757-2765
publicationName	The Journal of clinical investigation
startingPage	2757
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_3f38c209212cbbf7831260c7241d85bd
bibliographicCitation	Schultze JL, Michalak S, Seamon MJ, Dranoff G, Jung K, Daley J, Delgado JC, Gribben JG, Nadler LM. CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy. J Clin Invest. 1997 Dec 01;100(11):2757–65. PMID: 9389740; PMCID: PMC508480.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_daa38d97967c1d06f433be34e8134ce4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d7b6caa440b65b8615338c3fb3a0e000 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2f32608cb3455387b226e4e260dc13ef http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a652b46c1c82263f466ba397cd6b2e7c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c436bbb2910ec8757fa8867c6aa7e5fb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6812185ed612a84d30a803e983df4fed http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_84e9127ec85fd24940287c5760631a7d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0849d96c13c4f75a616176a95878da6e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e94150fb0369798ce6c0d235fcd941d3
date	1997-12-01^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/9389740 https://pubmed.ncbi.nlm.nih.gov/PMC508480 https://doi.org/10.1172/jci119822
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4632 https://portal.issn.org/resource/ISSN/0021-9738
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy.
discusses	http://id.nlm.nih.gov/mesh/M0025510 http://id.nlm.nih.gov/mesh/M0022735 http://id.nlm.nih.gov/mesh/M0028391 http://id.nlm.nih.gov/mesh/M0011490 http://id.nlm.nih.gov/mesh/M0001448 http://id.nlm.nih.gov/mesh/M0022202 http://id.nlm.nih.gov/mesh/M0001435 http://id.nlm.nih.gov/mesh/M0016224 http://id.nlm.nih.gov/mesh/M0259868
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D019013Q000276 http://id.nlm.nih.gov/mesh/D013601Q000276 http://id.nlm.nih.gov/mesh/D000938Q000276 http://id.nlm.nih.gov/mesh/D001402Q000276
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D016475 http://id.nlm.nih.gov/mesh/D003713Q000276 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D014407 http://id.nlm.nih.gov/mesh/D009980Q000276 http://id.nlm.nih.gov/mesh/D003362 http://id.nlm.nih.gov/mesh/D014763Q000138 http://id.nlm.nih.gov/mesh/D000951Q000276 http://id.nlm.nih.gov/mesh/D002478 http://id.nlm.nih.gov/mesh/D000956Q000276 http://id.nlm.nih.gov/mesh/D002455 http://id.nlm.nih.gov/mesh/D010446Q000138 http://id.nlm.nih.gov/mesh/D016219 http://id.nlm.nih.gov/mesh/D014442Q000276 http://id.nlm.nih.gov/mesh/D013997 http://id.nlm.nih.gov/mesh/D010446Q000276 http://id.nlm.nih.gov/mesh/D016753Q000378 http://id.nlm.nih.gov/mesh/D003713Q000166 http://id.nlm.nih.gov/mesh/D014763Q000276 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D007963Q000166 http://id.nlm.nih.gov/mesh/D007963Q000276 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D007371Q000096 http://id.nlm.nih.gov/mesh/D003601
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9601 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7d6a1edc08997e3d7b61d7a07051efb5 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a92f8ed870be1881ab70c89e8f2b1e38 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10364 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_87f11a2c599b2f3cfbbc816705b2fbee

Showing number of triples: 1 to 72 of 72.